fluoxetine has been researched along with Mental Disorders in 76 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to assess the efficacy and tolerability of fluoxetine treatment of acral lick dermatitis (ALD) in dogs and to investigate ALD as an animal model of obsessive-compulsive disorder (OCD)." | 9.08 | Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial. ( Berk, M; Wynchank, D, 1998) |
| "Affordable antidepressants such as fluoxetine should be the treatment of choice for common mental disorders in general health-care settings in India, since they are associated with improved clinical and economic outcomes, especially in the short term." | 5.10 | Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial. ( Andrew, G; Chisholm, D; Dias-Saxena, F; Mann, A; Patel, V; Rabe-Hesketh, S, 2003) |
| "The aim of the study was to assess the efficacy and tolerability of fluoxetine treatment of acral lick dermatitis (ALD) in dogs and to investigate ALD as an animal model of obsessive-compulsive disorder (OCD)." | 5.08 | Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial. ( Berk, M; Wynchank, D, 1998) |
| "Fluoxetine is an antidepressant commonly prescribed not only to adults but also to children for the treatment of depression, obsessive-compulsive disorder, and neurodevelopmental disorders." | 4.02 | Long-Term Fluoxetine Administration Causes Substantial Lipidome Alteration of the Juvenile Macaque Brain. ( Anikanov, N; Bobrovskiy, DM; Golub, MS; Horn, AKE; Khaitovich, P; Khrameeva, E; Ogurtsova, P; Park, DI; Petrova, D; Stekolshchikova, E; Tkachev, A; Turck, CW, 2021) |
| "The rate of spontaneous pregnancy loss did not differ significantly between the women treated with fluoxetine and the control women (10." | 3.69 | Birth outcomes in pregnant women taking fluoxetine. ( Chambers, CD; Dick, LM; Felix, RJ; Johnson, KA; Jones, KL, 1996) |
| "The objective of this study was to evaluate the pharmacokinetic profile of fluoxetine (FLX) and its major metabolite, norfluoxetine (NORFLX), in children and adolescent patients undergoing psychiatric treatment." | 2.70 | Fluoxetine pharmacokinetics in pediatric patients. ( Abrams, A; Biederman, J; Cohen, L; Faird, N; Neft, D; Sinha, V; Wilens, TE, 2002) |
| "Fluoxetine appears to be an effective and well-tolerated antidepressant in elderly inpatients of varying age, levels of depression, and psychiatric diagnoses." | 2.68 | The use and tolerability of fluoxetine in geropsychiatric inpatients. ( Kunik, ME; Molinari, V; Orengo, CA; Workman, RH, 1996) |
| "Fluoxetine was well tolerated and showed rapid onset of action." | 2.68 | Fluoxetine in the treatment of anger: an open clinical trial. ( Emmanuel, N; Johnson, MR; Lydiard, RB; Rubey, RN, 1996) |
| "The association between treatment-emergent suicidality as an adverse event and fluoxetine treatment was examined using a fluoxetine double-blind placebo-controlled database of clinical trials for indications other than major depressive disorder." | 2.44 | Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder. ( Ball, S; Beasley, CM; Disch, D; Plewes, J; Tauscher-Wisniewski, S, 2007) |
| "Sixteen trials studied patients with major depressive disorder, and the remaining 8 studied obsessive-compulsive disorder (n = 4), generalized anxiety disorder (n = 2), attention-deficit/hyperactivity disorder (n = 1), and social anxiety disorder (n = 1)." | 2.43 | Suicidality in pediatric patients treated with antidepressant drugs. ( Hammad, TA; Laughren, T; Racoosin, J, 2006) |
| "Emphasis is given to the treatment of depression and how the potential of one pure enantiomer-escitalopram, the S-enantiomer of the selective serotonin reuptake inhibitor citalopram-appears to be fulfilling its preclinical promise in the clinic." | 2.41 | Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram. ( Baumann, P; Eap, CB; Zullino, DF, 2002) |
| " The adverse reactions include the "serotonin syndrome", cardiovascular complications, extrapyramidal side effects such as akathisia, dyskinesias, and parkinsonian-like syndromes and an apparently increased risk of suicidality." | 2.38 | Fluoxetine: adverse effects and drug-drug interactions. ( Messiha, FS, 1993) |
| "Carbamazepine (CBZ) is an antiepileptic drug used as a mood stabilizer in child psychiatry." | 1.42 | [Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage]. ( Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S, 2015) |
| "Risperidone (N=45, 62%) was the most frequently prescribed antipsychotic drug, followed by olanzapine (24, 32%)." | 1.35 | Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. ( Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G, 2008) |
| " A significant correlation was found between the concentrations of each enantiomer and the prescribed daily dosage (r = 0." | 1.31 | Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response. ( Gatti, G; Guarneri, L; Jannuzzi, G; Magni, P; Pacifici, R; Perucca, E; Spina, E; Torta, R; Zuccaro, P, 2002) |
| "Trichotillomania is a chronic illness that may be difficult to treat." | 1.29 | Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. ( Aronowitz, B; Cohen, LJ; Hollander, E; Rosen, J; Simeon, D; Spadaccini, E; Stein, DJ, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.32) | 18.7374 |
| 1990's | 34 (44.74) | 18.2507 |
| 2000's | 26 (34.21) | 29.6817 |
| 2010's | 12 (15.79) | 24.3611 |
| 2020's | 3 (3.95) | 2.80 |
| Authors | Studies |
|---|---|
| Sagahón-Azúa, J | 1 |
| Medellín-Garibay, SE | 1 |
| Chávez-Castillo, CE | 1 |
| González-Salinas, CG | 1 |
| Milán-Segovia, RDC | 1 |
| Romano-Moreno, S | 1 |
| Sadowsky, J | 1 |
| Tkachev, A | 1 |
| Stekolshchikova, E | 1 |
| Bobrovskiy, DM | 1 |
| Anikanov, N | 1 |
| Ogurtsova, P | 1 |
| Park, DI | 1 |
| Horn, AKE | 1 |
| Petrova, D | 1 |
| Khrameeva, E | 1 |
| Golub, MS | 1 |
| Turck, CW | 1 |
| Khaitovich, P | 1 |
| Mitra, S | 1 |
| Mucha, M | 1 |
| Owen, S | 1 |
| Bult-Ito, A | 1 |
| Krooks, JA | 1 |
| Weatherall, AG | 1 |
| Holland, PJ | 1 |
| Maruf, AA | 1 |
| Greenslade, A | 1 |
| Arnold, PD | 1 |
| Bousman, C | 1 |
| Lam, D | 1 |
| Gorman, DA | 1 |
| Patten, S | 1 |
| Pringsheim, T | 1 |
| Rodriguez-Osorio, X | 1 |
| Fernandez-Pajarin, G | 1 |
| Arias-Rivas, S | 1 |
| Requena-Caballero, I | 1 |
| Lopez-Gonzalez, FJ | 1 |
| Arias, M | 1 |
| McEwen, BS | 1 |
| Fernandez, A | 1 |
| Dor, E | 1 |
| Menard, ML | 1 |
| Askenazy, F | 1 |
| Thümmler, S | 1 |
| Frazer, S | 1 |
| Otomo, K | 1 |
| Dayer, A | 1 |
| Mas, S | 1 |
| Blázquez, A | 1 |
| Rodríguez, N | 1 |
| Boloc, D | 1 |
| Lafuente, A | 1 |
| Arnaiz, JA | 1 |
| Lázaro, L | 1 |
| Gassó, P | 1 |
| Purper-Ouakil, D | 1 |
| Vitiello, B | 1 |
| Zubenko, GS | 1 |
| Jones, ML | 1 |
| Estevez, AO | 1 |
| Hughes, HB | 1 |
| Estevez, M | 1 |
| Pinna, G | 1 |
| Costa, E | 1 |
| Guidotti, A | 1 |
| McCall, WV | 1 |
| Nutt, DJ | 1 |
| Feetam, CL | 1 |
| McKinney, KA | 1 |
| Greenfield, BG | 1 |
| Jakubovski, E | 1 |
| Diniz, JB | 1 |
| Valerio, C | 1 |
| Fossaluza, V | 1 |
| Belotto-Silva, C | 1 |
| Gorenstein, C | 1 |
| Miguel, E | 1 |
| Shavitt, RG | 1 |
| Baumann, P | 1 |
| Zullino, DF | 1 |
| Eap, CB | 1 |
| Jannuzzi, G | 1 |
| Gatti, G | 1 |
| Magni, P | 1 |
| Spina, E | 2 |
| Pacifici, R | 1 |
| Zuccaro, P | 1 |
| Torta, R | 1 |
| Guarneri, L | 1 |
| Perucca, E | 1 |
| LLerena, A | 2 |
| Dorado, P | 2 |
| Berecz, R | 2 |
| González, A | 1 |
| Jesús Norberto, M | 1 |
| de la Rubia, A | 1 |
| Cáceres, M | 1 |
| Wilens, TE | 1 |
| Cohen, L | 1 |
| Biederman, J | 1 |
| Abrams, A | 1 |
| Neft, D | 1 |
| Faird, N | 1 |
| Sinha, V | 1 |
| Patel, V | 1 |
| Chisholm, D | 1 |
| Rabe-Hesketh, S | 1 |
| Dias-Saxena, F | 1 |
| Andrew, G | 1 |
| Mann, A | 1 |
| Dobscha, SK | 1 |
| Anderson, TA | 1 |
| Hoffman, WF | 1 |
| Winterbottom, LM | 1 |
| Turner, EH | 1 |
| Snodgrass, LS | 1 |
| Hauser, P | 1 |
| Kozyrev, VN | 1 |
| Smulevich, AB | 1 |
| Drobizhev, MIu | 1 |
| Kraeva, GK | 1 |
| Kubrakov, MA | 1 |
| González, AP | 1 |
| Peñas-LLedó, EM | 1 |
| McLeod, JD | 1 |
| Pescosolido, BA | 1 |
| Takeuchi, DT | 1 |
| White, TF | 1 |
| Seidel, JA | 1 |
| Hammad, TA | 1 |
| Laughren, T | 1 |
| Racoosin, J | 1 |
| Alacqua, M | 1 |
| Trifirò, G | 1 |
| Arcoraci, V | 1 |
| Germanò, E | 1 |
| Magazù, A | 1 |
| Calarese, T | 1 |
| Di Vita, G | 1 |
| Gagliano, C | 1 |
| Tauscher-Wisniewski, S | 1 |
| Disch, D | 1 |
| Plewes, J | 1 |
| Ball, S | 1 |
| Beasley, CM | 1 |
| Bolaños, CA | 1 |
| Willey, MD | 1 |
| Maffeo, ML | 1 |
| Powers, KD | 1 |
| Kinka, DW | 1 |
| Grausam, KB | 1 |
| Henderson, RP | 1 |
| Barton, R | 1 |
| Ibi, D | 1 |
| Takuma, K | 1 |
| Koike, H | 1 |
| Mizoguchi, H | 1 |
| Tsuritani, K | 1 |
| Kuwahara, Y | 1 |
| Kamei, H | 1 |
| Nagai, T | 1 |
| Yoneda, Y | 1 |
| Nabeshima, T | 1 |
| Yamada, K | 1 |
| Enna, SJ | 1 |
| Cohen, LJ | 1 |
| Stein, DJ | 1 |
| Simeon, D | 1 |
| Spadaccini, E | 1 |
| Rosen, J | 1 |
| Aronowitz, B | 1 |
| Hollander, E | 1 |
| Goldberg, HL | 1 |
| Alpert, JE | 1 |
| Maddocks, A | 1 |
| Rosenbaum, JF | 1 |
| Fava, M | 2 |
| Sigroth-Lambe, S | 1 |
| Lambe, M | 1 |
| Rubin, J | 1 |
| Szarek, BL | 1 |
| Brandt, DM | 1 |
| Messiha, FS | 2 |
| Patterson, WM | 1 |
| Terao, T | 1 |
| Herpertz-Dahlmann, B | 1 |
| Connor, DF | 1 |
| Benjamin, S | 1 |
| Ozbayrak, KR | 1 |
| Orengo, CA | 1 |
| Kunik, ME | 1 |
| Molinari, V | 1 |
| Workman, RH | 1 |
| DeVane, CL | 1 |
| Sallee, FR | 1 |
| Chambers, CD | 1 |
| Johnson, KA | 1 |
| Dick, LM | 1 |
| Felix, RJ | 1 |
| Jones, KL | 1 |
| Goldstein, DJ | 1 |
| Sundell, KL | 1 |
| Corbin, LA | 1 |
| Zajecka, J | 1 |
| Tracy, KA | 1 |
| Mitchell, S | 1 |
| Rubey, RN | 1 |
| Johnson, MR | 1 |
| Emmanuel, N | 1 |
| Lydiard, RB | 1 |
| Wynchank, D | 1 |
| Berk, M | 1 |
| Stahl, SM | 1 |
| Yager, J | 1 |
| Siegfreid, SL | 1 |
| DiMatteo, TL | 1 |
| Nurnberg, HG | 2 |
| Hensley, PL | 2 |
| Thompson, PM | 2 |
| Paine, SS | 1 |
| Weintrob, A | 1 |
| Michelson, D | 1 |
| Amsterdam, J | 1 |
| Apter, J | 1 |
| Londborg, P | 1 |
| Tamura, R | 1 |
| Tepner, RG | 1 |
| Szegedy-Maszak, M | 1 |
| Rothman, DJ | 1 |
| Wright, R | 1 |
| Fioramonti, J | 1 |
| Bueno, L | 1 |
| Delvaux, M | 1 |
| Frexinos, J | 1 |
| Ashleigh, EA | 1 |
| Fesler, FA | 1 |
| Downs, J | 1 |
| Ward, J | 1 |
| Farmer, R | 1 |
| Baldwin, D | 1 |
| Fineberg, N | 1 |
| Montgomery, S | 1 |
| Fernandez, F | 1 |
| Levy, JK | 1 |
| Beal, DM | 1 |
| Harris, D | 1 |
| Bartos, M | 1 |
| Korsak, C | 1 |
| Splane, G | 1 |
| Quant, R | 1 |
| Starke, J | 1 |
| Markowitz, PI | 1 |
| Mandos, L | 1 |
| Clary, C | 1 |
| Schweizer, E | 1 |
| Schifano, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Neurocognitive and Neuroimaging Variables Associated With Response to Treatment in Patients With OCD[NCT03993535] | Phase 4 | 250 participants (Actual) | Interventional | 2018-10-10 | Active, not recruiting | ||
| Improving Outcomes of Depression in Primary Care[NCT00105833] | 400 participants (Actual) | Interventional | 2002-07-31 | Completed | |||
| Transcranial Direct Current Stimulation (tDCS) for Depression in Pregnancy: A Pilot Study[NCT02116127] | 20 participants (Actual) | Interventional | 2014-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for fluoxetine and Mental Disorders
| Article | Year |
|---|---|
Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.
Topics: Antipsychotic Agents; Body Dysmorphic Disorders; Cognitive Behavioral Therapy; Fluoxetine; Humans; M | 2018 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytoc | 2019 |
[Recurrence of encephalitis after 25 years due to anti-NMDA receptor antibodies].
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Autoantibodies; Autoantigens; Crit | 2014 |
Biomarkers for assessing population and individual health and disease related to stress and adaptation.
Topics: Adaptation, Psychological; Allostasis; Animals; Antidepressive Agents, Second-Generation; Anxiety; A | 2015 |
[Use of psychotropic drugs in children].
Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Dis | 2008 |
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
Topics: Animals; Brain; Fluoxetine; gamma-Aminobutyric Acid; Humans; Mental Disorders; Mood Disorders; Pregn | 2009 |
Enantiomers' potential in psychopharmacology--a critical analysis with special emphasis on the antidepressant escitalopram.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Fluoxetine; Humans; Menta | 2002 |
Suicidality in pediatric patients treated with antidepressant drugs.
Topics: Adolescent; Age Factors; Antidepressive Agents; Child; Depressive Disorder, Major; Female; Fluoxetin | 2006 |
Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.
Topics: Age Distribution; Double-Blind Method; Fluoxetine; Humans; Incidence; Mental Disorders; Psychopathol | 2007 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; D | 2007 |
Psychotropic drugs in pregnancy and lactation.
Topics: Clozapine; Embryonic and Fetal Development; Female; Fluoxetine; Humans; Lactation; Lithium; Mental D | 1994 |
Fluoxetine: adverse effects and drug-drug interactions.
Topics: Drug Interactions; Extrapyramidal Tracts; Fluoxetine; Heart; Humans; Mental Disorders; Substance-Rel | 1993 |
Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms.
Topics: Animals; Antidepressive Agents; Fluoxetine; Humans; Mental Disorders | 1993 |
[Serotonergic antidepressants--indications for treating children and adolescents exemplified by fluoxetine and clomipramine].
Topics: Adolescent; Child; Clomipramine; Fluoxetine; Humans; Mental Disorders | 1993 |
Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience.
Topics: Adolescent; Adult; Age Factors; Child; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxe | 1996 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Femal | 1997 |
[Old and new physiopathological concepts of irritable bowel syndrome].
Topics: Adult; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agen | 2001 |
Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents; Anxiety Disorders; Bupropion; Depr | 1991 |
10 trials available for fluoxetine and Mental Disorders
| Article | Year |
|---|---|
Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Topics: Adult; Age Factors; Age of Onset; Cognitive Behavioral Therapy; Depressive Disorder; Female; Fluoxet | 2013 |
Fluoxetine pharmacokinetics in pediatric patients.
Topics: Adolescent; Child; Female; Fluoxetine; Humans; Male; Mental Disorders; Prospective Studies; Selectiv | 2002 |
Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial.
Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Double-Blind Method; Female; Fluoxe | 2003 |
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.
Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 C | 2004 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; | 1994 |
The use and tolerability of fluoxetine in geropsychiatric inpatients.
Topics: Age Factors; Aged; Antipsychotic Agents; Dementia; Depressive Disorder; Drug Therapy, Combination; F | 1996 |
Fluoxetine in the treatment of anger: an open clinical trial.
Topics: Adult; Ambulatory Care; Anger; Anxiety Disorders; Depressive Disorder; Female; Fluoxetine; Humans; M | 1996 |
Fluoxetine treatment of acral lick dermatitis in dogs: a placebo-controlled randomized double blind trial.
Topics: Animals; Antidepressive Agents, Second-Generation; Dermatitis; Disease Models, Animal; Dog Diseases; | 1998 |
Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Administration Sc | 1999 |
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial.
Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Fluoxetine; Humans; Male; Mental Disorders | 2000 |
48 other studies available for fluoxetine and Mental Disorders
| Article | Year |
|---|---|
Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.
Topics: Adult; Antipsychotic Agents; Anxiety; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Cytochrome | 2021 |
Before and After Prozac: Psychiatry as Medicine, and the Historiography of Depression.
Topics: Depression; Fluoxetine; Historiography; Humans; Mental Disorders; Psychiatry | 2021 |
Long-Term Fluoxetine Administration Causes Substantial Lipidome Alteration of the Juvenile Macaque Brain.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Fatty Acids, Unsaturated; Fluoxetine; Lipid Metabo | 2021 |
Postpartum Lactation-Mediated Behavioral Outcomes and Drug Responses in a Spontaneous Mouse Model of Obsessive-Compulsive Disorder.
Topics: Animals; Anxiety; Disease Models, Animal; Female; Fluoxetine; Lactation; Lactation Disorders; Mental | 2017 |
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; | 2013 |
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage].
Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug | 2015 |
Early-life serotonin dysregulation affects the migration and positioning of cortical interneuron subtypes.
Topics: Animals; Cell Membrane; Cerebral Cortex; Disease Models, Animal; Female; Fluoxetine; Gene Expression | 2015 |
Pharmacogenetic study focused on fluoxetine pharmacodynamics in children and adolescent patients: impact of the serotonin pathway.
Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Mental | 2016 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System | 2008 |
Identification of a CREB-dependent serotonergic pathway and neuronal circuit regulating foraging behavior in Caenorhabditis elegans: a useful model for mental disorders and their treatments?
Topics: Animals; Caenorhabditis elegans; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal | 2009 |
The treatment of comorbid insomnia.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Fluoxetine; Follow-Up Studies; | 2009 |
What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology.
Topics: Animals; Azabicyclo Compounds; Citalopram; Eszopiclone; Fluoxetine; Humans; Mental Disorders; Molecu | 2010 |
Self-compliance at 'Prozac campus'.
Topics: Anthropology, Cultural; Decision Making; Female; Fluoxetine; Humans; Male; Medication Adherence; Men | 2010 |
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Depression; Female; Fluoxetine; Humans; Male; Mental | 2002 |
Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients.
Topics: Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; | 2003 |
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration S | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepin | 2003 |
Public attitudes toward the use of psychiatric medications for children.
Topics: Antidepressive Agents, Second-Generation; Child; Female; Fluoxetine; Humans; Male; Mental Disorders; | 2004 |
Experience is a biochemical intervention: reconceptualizing the "biologically based mental illness".
Topics: Attitude to Health; Brain; Fluoxetine; Humans; Mental Disorders; Placebo Effect; Psychiatry; Selecti | 2005 |
Mental health: Prozac changes moods...and minds.
Topics: Antidepressive Agents, Second-Generation; Depression; Fluoxetine; Humans; Mental Disorders; Psychoth | 2005 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Ut | 2008 |
Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Conditioni | 2008 |
Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Behavior, Animal; Bromodeoxyuridine; Cell Pro | 2008 |
Brain serotonin receptors and neuropsychiatric disorders.
Topics: Animals; Brain; Desipramine; Fluoxetine; Humans; Imipramine; Kinetics; Lysergic Acid Diethylamide; M | 1981 |
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Behavior Therapy; Child; Child, Preschool; Clomip | 1995 |
Practical approaches to the treatment of social phobia.
Topics: Adrenergic beta-Antagonists; Behavior Therapy; Benzamides; Benzodiazepines; Bupropion; Clonazepam; C | 1994 |
[Cosmetic psychopharmacology. Prozac--an American happy pill and a gold mine].
Topics: Drug Utilization; Fluoxetine; Humans; Mental Disorders; United States | 1994 |
American institute for psychoanalysis. The president and Prozac.
Topics: Fluoxetine; Health Maintenance Organizations; Humans; Managed Care Programs; Mental Disorders; Natio | 1994 |
A comparison of weight changes with fluoxetine, desipramine, and amitriptyline: a retrospective study of psychiatric inpatients.
Topics: Amitriptyline; Body Weight; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination | 1993 |
Fluoxetine-induced sexual dysfunction.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Ejaculation; Fluoxetine; Huma | 1993 |
Titration of serotonin reuptake blockers.
Topics: Amantadine; Drug Administration Schedule; Fluoxetine; Humans; Mental Disorders; Recurrence; Selectiv | 1993 |
Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
Topics: Antipsychotic Agents; Dextroamphetamine; Diphenhydramine; Fluoxetine; Humans; Male; Mental Disorders | 1995 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Affective Symptoms; Birth Weight; Case-Co | 1996 |
Birth outcomes in pregnant women taking fluoxetine.
Topics: Abnormalities, Drug-Induced; Female; Fluoxetine; Humans; Infant, Newborn; Infant, Newborn, Diseases; | 1997 |
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine | 1998 |
Use of alternative remedies by psychiatric patients: illustrative vignettes and a discussion of the issues.
Topics: Adult; Anorexia Nervosa; Cognitive Behavioral Therapy; Combined Modality Therapy; Complementary Ther | 1999 |
Modeling the pharmacoeconomic cost of three selective serotonin reuptake inhibitors.
Topics: Dose-Response Relationship, Drug; Fluoxetine; Follow-Up Studies; Humans; Mental Disorders; Mental He | 1999 |
Pediatric psychopharmacology.
Topics: Antidepressive Agents, Second-Generation; Child; Dose-Response Relationship, Drug; Fluoxetine; Human | 2000 |
The career of a celebrity pill. As Prozac's long reign comes to an end, experts are questioning its legacy.
Topics: Antidepressive Agents, Second-Generation; Fluoxetine; Humans; Mental Disorders; Patents as Topic; Un | 2001 |
Shiny, happy people: the problem with "cosmetic psychopharmacology.
Topics: Behavior; Behavior Control; Depressive Disorder; Female; Fluoxetine; Genetic Determinism; Genetic En | 1994 |
The coverage of happiness: when Prozac meets universal coverage.
Topics: Behavior; Behavior Control; Biomedical Enhancement; Delivery of Health Care; Depressive Disorder; Dr | 1994 |
Fluoxetine and suicidal preoccupation.
Topics: Ambulatory Care; Chronic Disease; Depressive Disorder; Female; Fluoxetine; Humans; Incidence; Male; | 1992 |
Preoccupation with suicide in patients treated with fluoxetine.
Topics: Fluoxetine; Humans; Limbic System; Mental Disorders; Suicide | 1991 |
Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
Topics: Adult; Basal Ganglia Diseases; Female; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Middle Age | 1991 |
Safety and efficacy of fluoxetine.
Topics: Fluoxetine; Hospitalization; Humans; Mental Disorders; Suicide | 1991 |
Fluoxetine treatment of self-injurious behavior in mentally retarded patients.
Topics: Adult; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Mental Disorders; Middle | 1990 |
Prescribing practices for fluoxetine: a brief survey.
Topics: Adult; Drug Utilization; Female; Fluoxetine; Humans; Male; Mental Disorders; Middle Aged; Pennsylvan | 1990 |
[Fluoxetine hydrochloride].
Topics: Animals; Cats; Dogs; Drug Evaluation; Fluoxetine; Humans; Mental Disorders; Mice; Rats | 1990 |